Depression is often undetected and untreated among respiratory insufficiency patients. 8 According to previous reports, less than a third of COPD patients suffering from depression are being treated for it. [9] [10] [11] There are several possible reasons for the low detection rate. First, the diagnosis of depression is challenging, because the symptoms of pulmonary disease may resemble those of depression. In addition, both patients and health-care personnel may consider psychiatric symptoms a normal reaction to having progressive illness rather than suspecting comorbid psychiatric disease. 12 Finally, depression is rarely screened for in routine health care. As comorbid depression is widely undetected, routine screening for depression has been recommended. 13, 14 Nevertheless, screening should only be performed if a local depression treatment pathway with the possibility of consulting a psychiatrist has been established. 13 Thus, it is essential to implement not only the screening instrument but also a care pathway allowing appropriate diagnostics and treatment for patients with positive screening results. However, the implementation of new protocols in clinical practice is usually challenging, and a variety of problems may arise at different organisational levels. 15, 16 In this paper, we describe the implementation and preliminary results of a depression screening protocol among respiratory insufficiency patients at a pulmonary outpatient clinic. To the best of our knowledge, such care pathways have not been described previously.
| MATERIALS AND METHODS

| Setting
Tampere University Hospital is a tertiary hospital situated in the southern part of Finland. It provides specialised care to about 530,000 people living in 23 municipalities situated within a 110 km radius from the city of Tampere. Patients with respiratory diseases are treated at the outpatient clinic; the annual volume is about 14 000 visits by 4500 patients. At the outpatient clinic, there is a specialised section for respiratory insufficiency patients; its annual volume is approximately 500 patients.
The patients are referred to the respiratory insufficiency section by physicians working in primary, private or specialised health care. Typically, the patients have a severe lung, heart or neurological disease with suspected chronic respiratory insufficiency. At the clinic, a pulmonologist meets the patient, considers the differential diagnosis, and makes decisions about medications and possible device treatments (long-term oxygen therapy (LTOT) and/or non-invasive ventilation (NIV)). A multidisciplinary team consisting of a nurse, a physiotherapist, a social worker, a dietician and a rehabilitation counsellor participates in the care. Follow-up is organised according to a discrete protocol.
| Implementation of the depression screening protocol
When interviewing the patients at the outpatient clinic, nurses have noticed that the patients often have depressive symptoms but no treatment for depression. The nurses also noted their lack of knowledge of how to approach such symptoms, especially as patients with chronic respiratory insufficiency often have difficulties in seeking help because of restricted functional ability.
From this background, we decided to start the development and implementation of a depression screening protocol. The protocol was developed in collaboration with the general hospital psychiatric unit. For this project, a contract was drawn up to allow the referral of screening-positive patients to the psychiatric outpatient clinic even though the usual referral criteria were not met. The personnel of the pulmonary unit were educated about depression detection by lectures and group discussions. The aim was to improve the identification of depressive symptoms, bring up mood symptoms in discussion, and enhance their further evaluation and treatment.
The Depression Scale (DEPS) was selected as the screening instrument. The DEPS is a validated, self-rated screening tool for depression. 17 It is the primary screening instrument for depression at Tampere University Hospital. The DEPS questionnaire consists of 10 items, and scores vary from 1 to 30 points. The cut-off point for depressive symptoms is ≥9, while the cut-off point for clinical depression is ≥12. 18 Screening commenced in the autumn of 2015. Nurses were instructed to administer the DEPS questionnaire to every patient visiting the respiratory insufficiency section. A referral to an appointment at the psychiatric outpatient clinic was offered to patients with a positive screening. A pulmonologist made the referral, and the patient was later informed of the appointment time. In 2015, the cut-off for referral was ≥12/30 points. In 2016, the cut-off was lowered to ≥9/30 to include patients with milder symptoms. According to Sheehan and McGee, 19 a lower cut-off score increases the possibility of identifying depression (greater sensitivity), whereas a higher cut-off score diminishes false-positive results (greater specificity) at the cost of sensitivity. questionnaire; (3) the proportion of patients with positive DEPS scores; (4) the patient characteristics associated with high DEPS scores; and (5) the consequences of positive screenings.
To identify patients at an elevated risk for depression, we registered each patient's age, gender, use of walking aids and home care, living arrangements, smoking history, pulmonary disease diagnosis, causes for chronic respiratory insufficiency, other diagnoses, use of psychoactive medications, available measurements of lung function (FEV 1 in post-bronchodilator spirometry), and functional exercise capacity (6-Minute Walk test, 6MWT). In addition, the measurements made during the visit were gathered, including the patient's height, weight, microspirometry, and the scores of the Alcohol Use Disorders Identification Test (AUDIT-C), 20 the modified Medical Research Council Dyspnoea Scale (mMRC), 21 and the COPD Assessment Test (CAT). 22 Spirometry was performed using the Vmax 20 spirometer (Sensor-Medics, Yorda Linda, California, USA) and microspirometry was performed using a microspirometer (Vitalograph copd-6, Vitalograph, Ennis, Ireland).
| Statistics
The process of the depression screening protocol is reported descriptively. To identify patient groups with a high prevalence of depression symptoms, the associations of the abovementioned patient characteristics with DEPS scores <9 vs ≥9 and <12 vs ≥12 were analysed. In addition, the results of microspirometry, spirometry, 6MWT, CAT, mMRC and AUDIT-C were compared with the DEPS scores. Statistical significance between groups was analysed using the Mann-Whitney U test, the chi-squared test or Fisher's test as appropriate. A P-value <0.05 was considered statistically significant. Data management and analysis were performed using IBM SPSS Statistics 23.
| Ethics
The implementation of depression screening in routine care was part of development work at the pulmonary outpatient clinic. The patients could refuse to fill the DEPS questionnaire. The retrospective study was organised to evaluate the outcomes of the screening, and the patients were not approached by the researchers. Prior to commencing the study, permission was acquired from the Science Centre of Tampere University Hospital.
| RESULTS
| Baseline characteristics of the patients
In total, 242 patients visited the respiratory insufficiency section during the defined time periods. Four patients using ventilators were excluded, leaving 238 for evaluation. Table  1 illustrates the characteristics of the included patients. Of the patients, 38 (16%) were attending their first visit, while the remainder had made earlier visits. A third of the patients attended a nurse's visit only; the rest met both a nurse and a physician.
Most patients had a diagnosis of chronic respiratory insufficiency (n = 200, 84%), and in 75% (n = 150) the diagnosis had been made less than 5 years ago. Nearly half of these patients (n = 82) were considered to have more than one disease diagnosis as the cause for their respiratory insufficiency. The most common diagnoses were COPD (n = 105, 53%), obstructive sleep apnoea (n = 66, 33%) and obesity hypoventilation (n = 54, 27%). Other diagnoses related to respiratory insufficiency were pulmonary fibrosis (n = 17, 9%), pulmonary hypertension (n = 17, 9%), neurological disorders (n = 14, 7%), deformities of the chest wall (n = 9, 5%), elevated hemidiaphragm (n = 7, 4%) and miscellaneous causes (n = 11, 6%). Hypertension (n = 134, 56%), type 2 diabetes (n = 80, 34%) and coronary artery disease (n = 46, 23%) were the most common comorbidities. Forty-five patients (19%) had a previous diagnosis of depression, 16 (7%) had another psychiatric diagnosis and 17 (7%) had a memory disorder. Thirty-eight patients (16%) were using antidepressants, 88 (37%) were using anxiolytic drugs and 23 (10%) were using antipsychotics.
| Outcomes of the screening
The DEPS questionnaire was filled by 74% of the patients (n = 176). The proportion of the patients that completed the DEPS questionnaire increased from 66% in the first year to 88% in the second year. Only six patients refused to fill the DEPS questionnaire. The unscreened patients were younger and had a lung disease diagnosis other than COPD more often compared to the screened patients.
Depression screening was positive in a quarter to a third of the patients, depending on the cut-off point (Figure 1 ). Referral to psychiatric services was offered to most patients with a positive screening. However, more than three quarters of them declined the referral. The reasons for declining the referral were not systematically recorded, but there were a few notes relating to difficulties with travelling, and indeed, 19 of the 24 patients who declined the referral lived outside the city of Tampere where the psychiatric clinic is situated.
Altogether, 13 referrals were made. Seven patients met a nurse or a psychologist at the psychiatric outpatient clinic. Of the remaining patients, four could not travel to the clinic; instead, they received a phone call to assess the severity of symptoms. Two patients died before the time of the appointment. All patients visiting the clinic were deemed depressive. After one or two visits, all patients were directed to further care at regional psychiatric services. Table 2 illustrates the associations of the DEPS scores with the patients' characteristics. High DEPS scores were common in patients who used walking aids or had a history of depression or heavy smoking. Depression screening was positive in 44% of the COPD patients, 38% of the sleep apnoea patients and 29% of the obesity hypoventilation syndrome patients. Depression screening was positive in 43% of the patients using LTOT and 33% of the patients using NIV. Screening was positive in 58% of the patients with a history of depression and in 44% of the patients using antidepressants. Table 3 illustrates the associations of the DEPS scores with the measurements of lung function and assessment tests. The patients with high DEPS scores also had high scores in the CAT and mMRC tests. The FEV 1 in spirometry and in microspirometry, AUDIT-C scores and distance in 6MWT were not associated with the DEPS scores.
| Identifying the patients with a positive depression screening
| DISCUSSION
| Symptoms of depression
Supporting earlier observations, 4,6,7 symptoms of depression were prevalent in patients: depression screening was positive in a third of patients. In line with earlier observations, 3,9 only a minority had a prior diagnosis of depression or were using antidepressants, underlining the need for depression screening. Prior depression, a long smoking history and the use of walking aids were associated with having symptoms of depression. In addition, symptomatic COPD patients with functional limitations owing to dyspnoea often experienced depression symptoms. Daily smoking has been shown to be a risk factor for depression, 22 and prior depression predisposes to new depression. 23 A relationship between CAT scores >20 and depression has been reported previously. 24, 25 Furthermore, the perception of dyspnoea is related to psychological factors, meaning that symptoms of depression increase dyspnoea. 26 Therefore,
high CAT or mMRC scores should be taken as sign warranting broader evaluation of the patient beyond lung disease-specific aims. 
| Implementation of depression screening
The challenges that we met when implementing the screening protocol can be divided into three groups based on the integrated checklist of determinants of practice (the TICD checklist) 28 : individual health professional factors, patient factors and professional interactions. Individual health professional factors include knowledge and skills, attitudes, and professional behaviour. 28 The acceptability of the screening among nurses, measured as the proportion of patients who received the DEPS questionnaire, was not good in the first year of screening, but it improved in the second year. Nevertheless, one in ten patients went unscreened in the second year, although in itself, the inclusion of the DEPS questionnaire in the clinic visit appeared feasible. The nurses felt comfortable asking the patients to fill the DEPS questionnaire, but they experienced difficulties regarding how to discuss positive screening results with the patients. Future education of the health-care professionals at the pulmonary clinic should therefore focus on communication and supportive discussion with a depressed patient. Emphasising the importance of separating the symptoms of depression from those of pulmonary disease-and seeing improvement in both symptoms and quality of life when mood disorder is treated-would help in motivating for systematic, continuous use of the screening tool.
Patient factors include beliefs and knowledge, motivation, and behaviour. 28 The acceptability of completing T A B L E 2 Association of the DEPS scores with the patients' baseline characteristics in two groups with different cut-off points (DEPS <9 vs ≥9 and DEPS <12 vs ≥12) the DEPS questionnaire was good, but the acceptability of referral for further evaluation was not: most of the screening-positive patients declined referral. This may partly be explained by geographical obstacles, but there are other possible explanations. Generally, COPD patients tend to deny depressive symptoms and usually refuse to accept referral to psychiatric services. 12, 29 The fear of stigmatisation concerning a psychiatric diagnosis may be one reason. Moreover, being unaware of the symptoms of depression, many patients may think that feeling depressed is a normal reaction to having a progressive somatic illness. 8 Therefore, after a positive depression screening, it is important to educate patients about depression and to explain the potential advantages of seeking help. 12 More than one discussion may be needed to achieve this. Professional interactions include communication, team processes and referral processes. 28 We failed to equip the professional teams with adequate skills and resources. Implementing a new protocol in clinical practice successfully requires changes in diverse levels of care and time for adjustments. In particular, the nurses at the pulmonary clinic lacked time and knowledge, and there were insufficient resources to have a psychiatric nurse attend the pulmonary outpatient clinic to interview the patients there. In addition, local care pathways for depression in surrounding communities were not involved in the protocol. In conclusion, the capacity for organisational change was not sufficient to manage patients with a positive screening. After the implementation of the screening, the detection of depressive symptoms certainly improved, but it is unclear how the screening affected the patients' clinical course. Optimally, the detection and treatment of depression would improve quality of life and also reduce the pulmonary disease symptoms. 30 Therefore, screening for depression is recommendable, but the issue to be resolved is how to organise services so that they are both accessible and acceptable from the patients' point of view. In the future, greater efforts are needed to ensure that appropriate discussion is available after a positive screening and further evaluation of mood is more accessible for the patients. Taken together, one solution would be to conduct a further evaluation of mood at the pulmonary clinic alongside screening instead of referring patients to a psychiatric unit. For the patients, the pulmonary unit is a natural environment to deal with the comorbidities of the pulmonary disease. The fear of stigmatisation related to the diagnosis of depression would likely be lower in pulmonary than psychiatric unit. Furthermore, such approach would reduce the need for separate hospital visits that would be burdensome to the patients. The problems to be solved include clarifying who is competent to perform the evaluation and how the resources should be guided so that the patients receive T A B L E 3 The associations of DEPS scores with lung function parameters, walking test distance and assessment tests in two groups with different cut-off points (DEPS <9 vs ≥9 and DEPS <12 vs ≥12) a timely evaluation. However, the best solution for the patients would probably be a care pathway that is connected to local health care, enabling the patients to receive evaluation and treatment (when necessary) close to their homes. This is challenging, however, because practices and the availability of services concerning the suspicion of depression vary greatly between municipalities.
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| Limitations
This evaluation was part of developmental work at the pulmonary outpatient clinic. These data must be interpreted with caution because our study was a retrospective evaluation of depression screening outcomes. One weakness was that neither the patients nor the nurses were systematically interviewed for the study; thus, not all possible contributing factors were fully clarified. Our initial purpose was not to search for patient groups with an elevated risk for depression, but some risk groups were nevertheless identified in the evaluation.
| CONCLUSION
Unnoticed symptoms of depression are prevalent among patients with chronic respiratory insufficiency. After commencing a protocol for depression screening in the pulmonary outpatient clinic, the detection of depression symptoms improved, but the effects on the patients' clinical course were small. The patients' compliance with the further evaluation of mood was poor. Screening for depression is recommendable, but the further assessment of patients with a positive screening should be organised in a way that is more acceptable and achievable from the patient's point of view. Instead of referring patients to a psychiatric unit, the evaluation and management of depression should rather be performed in the pulmonary unit.
